These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33631104)

  • 21. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
    Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and
    Wang J; Reiss K; Shi Y; Lolis E; Lisi GP; Batista VS
    Biochemistry; 2021 Jun; 60(24):1869-1875. PubMed ID: 34110129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19.
    Hashemian SM; Farhadi T; Velayati AA
    Drug Des Devel Ther; 2020; 14():3215-3222. PubMed ID: 32821086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Dependent RNA Polymerase as a Target for COVID-19 Drug Discovery.
    Zhu W; Chen CZ; Gorshkov K; Xu M; Lo DC; Zheng W
    SLAS Discov; 2020 Dec; 25(10):1141-1151. PubMed ID: 32660307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Simple
    Lu G; Zhang X; Zheng W; Sun J; Hua L; Xu L; Chu XJ; Ding S; Xiong W
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the molecular structure of Remdesivir for the treatment of Covid-19.
    Sheikholeslami SM; Jahanbani A; Shao Z
    Comput Methods Biomech Biomed Engin; 2021 Jul; 24(9):995-1002. PubMed ID: 33356621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theaflavin-3'-O-gallate a Black-tea Constituent Blocked SARS CoV-2 RNA dependant RNA Polymerase Active-site with Better Docking Results than Remdesivir.
    Banerjee A; Kanwar M; Maiti S
    Drug Res (Stuttg); 2021 Oct; 71(8):462-472. PubMed ID: 34517419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis.
    Focosi D; Maggi F; McConnell S; Casadevall A
    Antiviral Res; 2022 Feb; 198():105247. PubMed ID: 35033572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir.
    Tang W-F; Chang Y-H; Lin C-C; Jheng J-R; Hsieh C-F; Chin Y-F; Chang T-Y; Lee J-C; Liang P-H; Lin C-Y; Lin G-H; Cai J-Y; Chen Y-L; Chen Y-S; Tsai S-K; Liu P-C; Yang C-M; Shadbahr T; Tang J; Hsu Y-L; Huang C-H; Wang L-Y; Chen CC; Kau J-H; Hung Y-J; Lee H-Y; Wang W-C; Tsai H-P; Horng J-T
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0095623. PubMed ID: 38446062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.
    Lo MK; Albariño CG; Perry JK; Chang S; Tchesnokov EP; Guerrero L; Chakrabarti A; Shrivastava-Ranjan P; Chatterjee P; McMullan LK; Martin R; Jordan R; Götte M; Montgomery JM; Nichol ST; Flint M; Porter D; Spiropoulou CF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26946-26954. PubMed ID: 33028676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients.
    Boshier FAT; Pang J; Penner J; Parker M; Alders N; Bamford A; Grandjean L; Grunewald S; Hatcher J; Best T; Dalton C; Bynoe PD; Frauenfelder C; Köeglmeier J; Myerson P; Roy S; Williams R; de Silva TI; Goldstein RA; Breuer J;
    J Med Virol; 2022 Jan; 94(1):161-172. PubMed ID: 34415583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2.
    Simonis A; Theobald SJ; Fätkenheuer G; Rybniker J; Malin JJ
    EMBO Mol Med; 2021 Jan; 13(1):e13105. PubMed ID: 33015938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
    Jung LS; Gund TM; Narayan M
    Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Remdesivir Incorporation along the Primer Strand on SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Naseem-Khan S; Berger MB; Leddin EM; Maghsoud Y; Cisneros GA
    J Chem Inf Model; 2022 May; 62(10):2456-2465. PubMed ID: 35435671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remdesivir: Quo vadis?
    De Clercq E
    Biochem Pharmacol; 2021 Nov; 193():114800. PubMed ID: 34678228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action.
    Tchesnokov EP; Gordon CJ; Woolner E; Kocinkova D; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Nov; 295(47):16156-16165. PubMed ID: 32967965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual Screening and Quantum Chemistry Analysis for SARS-CoV-2 RNA-Dependent RNA Polymerase Using the ChEMBL Database: Reproduction of the Remdesivir-RTP and Favipiravir-RTP Binding Modes Obtained from Cryo-EM Experiments with High Binding Affinity.
    Tsuji M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir.
    Liang C; Tian L; Liu Y; Hui N; Qiao G; Li H; Shi Z; Tang Y; Zhang D; Xie X; Zhao X
    Eur J Med Chem; 2020 Sep; 201():112527. PubMed ID: 32563812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.